GLENVIEW CAPITAL MANAGEMENT, LLC is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q4 2025, the fund manages $4.9B in reported equity holdings across 57 positions. The largest holdings are CVS (13.2%), TEVA (10.6%), GPN (9.3%), THC (8.0%), AMZN (4.3%). The portfolio is concentrated in Other (74.5%), Healthcare (15.5%), Technology (5.0%). Data sourced from SEC EDGAR 13F filings (CIK 1138995).